Brinda, B J <br/><br/>
Use of tigecycline for the management of Clostridium difficile colitis in oncology patients and case series of breakthrough infections.  [electronic resource] 

 -  The Journal of hospital infection  Apr 2017 
 - 426-432 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-2939 
<br/><br/><label>Standard No.: </label>10.1016/j.jhin.2016.12.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Academic Medical Centers<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Bacterial Agents--therapeutic use<br/>Clostridioides difficile--drug effects<br/>Clostridium Infections--drug therapy<br/>Colitis--drug therapy<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Minocycline--analogs & derivatives<br/>Neoplasms--complications<br/>Retrospective Studies<br/>Tigecycline<br/>Treatment Outcome<br/>Young Adult